What Vivo Bio Tech does

Vivo Bio Tech Ltd. is a Hyderabad-based preclinical Contract Research Organization (CRO) founded in 1987 and listed on the Bombay Stock Exchange (BSE: 511509). The company operates an OECD-GLP-accredited, AAALACi-certified preclinical testing facility with 200+ employees, servicing pharmaceutical, agrochemical, medical device, vaccine, and nutraceutical sponsors in India and internationally across the USA, Canada, EU, UK, Japan, Singapore, China, Korea, Thailand, Australia, and South Africa.

The company's core offering is an integrated preclinical development platform covering in vivo and in vitro efficacy and safety studies, regulatory toxicology, and GLP-compliant study execution, supported by an in-house Specific Pathogen Free (SPF) animal breeding program. VBT claims to be the first Indian producer of SPF animals for biomedical research, a capability established in 2009, and reports more than 6,500 GLP studies over 30+ years. The technical stack is anchored in CPCSEA-approved animal husbandry, certified vivaria, and study director-led toxicology protocols rather than proprietary AI or computational tooling. The 2025 launch of a Large Animal Facility extends the platform from rodent- and rabbit-based work toward large-animal safety and medical-device (ISO 10993) studies.

Vivo Bio Tech monetizes its preclinical CRO services on a fee-for-service / per-study basis, with revenue tied to study volume, duration, and species. The customer base spans more than 500 sponsors including disclosed enterprise clients Cipla and Dr. Reddy's Laboratories, supplemented by a Cyagen Biosciences distribution partnership for transgenic and gene-modified mouse models that opens a higher-margin product revenue line. Geographic and vertical diversification is being expanded through a new facility at the Andhra Pradesh MedTech Zone in Visakhapatnam and entry into the vaccines and medical device segments, while multiple 2025 warrant-driven equity issues and related-party transactions with the promoter group point to active capital deployment behind this growth agenda.

Name

Vivo Bio Tech

Legal name

Vivo Bio Tech Ltd.

Website

https://vivobio.com

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

101–250 employees

Short description

Vivo Bio Tech (BSE: 511509) is a Hyderabad-based, OECD-GLP-accredited preclinical CRO providing in vivo and in vitro toxicology, efficacy, and regulatory services to 500+ pharmaceutical, agrochemical, medical device, vaccine, and nutraceutical sponsors globally.

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

Keywords

• Preclinical contract research
• GLP toxicology testing
• SPF laboratory animals
• Medical device preclinical
• Drug discovery services

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Preclinical Contract Research Services: Comprehensive preclinical testing services across pharmaceuticals, agrochemicals, medical devices, vaccines, nutraceuticals, and cosmetics industries. Services include toxicology studies, pharmacology, pharmacokinetics, analytical services, and regulatory support.
2. SPF Animal Breeding & Distribution: Supply of international quality laboratory animals including rats, mice, guinea pigs, and specialized immunodeficient models. Partnership with Cyagen for distribution of genetically modified mouse and rat models in India.
3. Custom Breeding Solutions: Dedicated area breeding programs with 400 or 250 sq.ft facilities including cage systems, LAF, and weighing balance. Includes model design, generation, maintenance, expansion, and door delivery of cohorts.
4. Pharmacology Services: Cell-based xenograft models, syngenic models, chemical-induced cancer models, diet-induced obesity models, and cell-based assays for drug discovery and preclinical research.
5. Lease Lab Facilities: Dedicated utility floors and 8 independent labs (suites) of 1600 sq.ft each available for lease to avoid contamination risk. Separate entry and exit for breeding and experimentation.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Vivo Bio Tech is a preclinical Contract Research Organization (CRO) that provides integrated discovery, development, and regulatory services to pharmaceutical, agrochemical, medical device, vaccine, nutraceutical, and cosmetics companies. The company operates an OECD-GLP accredited, AAALACi certified 150,000 sq ft testing facility across 53 acres in Hyderabad, India, complemented by an SPF (Specific Pathogen-Free) laboratory animal breeding and distribution business including rats, mice, guinea pigs, and immunodeficient models.

Product overview

Vivo Bio Tech is a preclinical Contract Research Organization (CRO) offering an integrated platform combining SPF (Specific Pathogen-Free) animal breeding and distribution with comprehensive preclinical testing services. The company operates through two main service lines: Supply services (SPF animal breeding, custom breeding solutions, lab animal diet supply, animal matrix products, lease labs, and custom model generation) and Testing Services (Pharmaceuticals, Medical Devices/MISE, Agrochemicals, Vaccines, Lab Animal Diagnostics, and Pharmacology). The 150,000 square-foot facility in Hyderabad spans 53 acres and is OECD GLP accredited and AAALACi certified, providing services from early discovery through regulatory submission support.

Differentiator

Problem solved

Functional benefit

Products and services

• SPF Animal Breeding & Distribution Supply of Specific Pathogen-Free (SPF) laboratory animals including rats, mice, and guinea pigs bred under international quality standards, distributed in partnership with Cyagen Biosciences. Targets research organizations and pharmaceutical companies requiring high-quality animal models.
• Custom Breeding Solutions Dedicated breeding facilities with controlled environments (250-400 sq.ft) providing custom breeding services for genetically modified animal models with full health monitoring and genotyping support. Includes SPF guinea pigs and door-delivery of cohorts.
• Lab Animal / Custom Diet Supply Supply of precisely formulated laboratory animal diets manufactured by Special Diets Services (SDS), including standard and custom formulations for various species including rats, mice, guinea pigs, and rabbits.
• Animal Matrix Supply of biological samples including blood, plasma, serum, organs, and urine from laboratory animals for research purposes.
• Lease Labs Laboratory space rental service offering 8 independent lab suites (1600 sq.ft each) with separate breeding and experimentation areas, satellite facilities, and customized rooms for studies.
• Custom Model Generation Generation of custom genetically modified mouse and rat models including knockout (KO) and knock-in (KI) models through partnership with Cyagen Biosciences.
• Pharmaceuticals Testing Services Comprehensive preclinical testing services for pharmaceutical compounds including toxicology (acute to carcinogenicity), genetic toxicology, pharmacokinetics, and pathology studies across multiple species. Supports IND and NDA-enabling studies, impurity qualification, biodistribution, bridging studies, and DMPK.
• Medical Devices Testing Services (MISE) Medical Investigations for Safety and Efficacy (MISE) unit providing preclinical testing for medical devices including implants, cardiovascular devices, surgical instruments, and PPE with GLP and ISO compliance. Data recognized by USFDA (510K & PMA), EU (CE Marking).
• Agrochemicals Testing Services GLP-compliant preclinical testing for agrochemicals including acute toxicity, repeated dose studies, mutagenicity, ecotoxicology, and physico-chemical analysis for regulatory submissions including REACH compliance.
• Vaccines Testing Services Preclinical studies for vaccine development including immunogenicity testing, safety assessments, toxicology, and challenge models to evaluate protective efficacy.
• Lab Animal Diagnostics Comprehensive health monitoring services for laboratory animals (mouse, rat, rabbit, guinea pig, hamster) testing for bacteria, viruses, parasites, and fungi using PCR, RT-PCR, microscopy, and culture methods.
• Pharmacology Services In-vivo and in-vitro pharmacology studies including xenograft cancer models, syngenic models, chemical-induced cancer models, diet-induced obesity studies, and anti-fungal efficacy testing.

Quantifiable outcome

• 652% profit increase to Rs 1.26 crore standalone net profit in Q3 FY2025
• +3 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Cyagen BiosciencescoreTechnology or IntegrationVivo Bio Tech entered into an agreement with Cyagen Biosciences to gain rights to breed and distribute select Cyagen mouse and rat models in India. Cyagen is a global provider of genetically modified mouse and rat models and services, and is the world's largest provider of transgenic and knockout mouse and rat services.
• Special Diets Services (SDS)coreOthersSDS has been manufacturing precisely formulated and controlled diets for laboratory species for over a quarter of a century. They are the largest supplier of Laboratory Animal diets in Europe and the only dedicated manufacturer in the UK. Vivo Bio Tech uses SDS diets including FD2 for guinea pigs fortified with ascorbyl polyphosphate.
• Elm Hill Labs, USAminorOthersSPF guinea pig breeders sourced from Elm Hill Labs, USA for Vivo Bio Tech's dedicated class 100,000 guinea pig facility.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Syngene International: Bengaluru-based preclinical and clinical CRO offering toxicology, DMPK, and discovery services to global pharma. Comparable to Vivo Bio Tech as an Indian-headquartered preclinical CRO serving global sponsors with GLP-accredited capabilities.
• Aragen Life Sciences: Hyderabad-headquartered contract research organization with discovery, development, and preclinical safety services. Directly comparable given overlapping service lines (toxicology, DMPK, pharmacology) and Indian base serving global pharma.
• GVK Biosciences: Indian CRO offering discovery, clinical research, and preclinical services. Comparable as a domestic peer with overlapping toxicology and drug development capabilities; notably, Vivo Bio Tech's president previously held a role at GVK Biosciences.
• Cyagen Biosciences: Global provider of genetically modified mouse and rat models and custom breeding services. Comparable to Vivo Bio Tech's SPF animal and custom model generation lines; the two are also commercial partners for distributing Cyagen models in India.
• Sai Life Sciences: Indian CRO providing drug discovery, development, and contract manufacturing services including preclinical toxicology. Comparable to Vivo Bio Tech in scale and as a Hyderabad-region competitor serving global pharma and biotech.

Broad incumbents

• Suven Life Sciences: Indian CRO/CDMO providing drug discovery, development, and specialty manufacturing. Comparable to Vivo Bio Tech as a domestic peer with overlapping preclinical and toxicology capabilities, though operating at materially larger scale.
• Piramal Pharma Solutions: Large Indian-headquartered CRO/CDMO offering preclinical, clinical, and manufacturing services. Comparable as a broader incumbent offering overlapping preclinical toxicology and DMPK services at greater scale than Vivo Bio Tech.
• Wuxi AppTec: China-headquartered global CRO/CDMO with preclinical toxicology, DMPK, and safety assessment services. Comparable to Vivo Bio Tech on service scope, though operating at much larger scale and serving as a major Asia-based alternative.
• Labcorp (Covance): Global CRO with extensive preclinical toxicology, safety, and DMPK capabilities. Comparable to Vivo Bio Tech as a much larger incumbent offering overlapping GLP preclinical services to pharma and medical-device clients worldwide.
• Charles River Laboratories: Global preclinical CRO and supplier of SPF research models, including toxicology, DMPK, and safety assessment. Closely comparable to Vivo Bio Tech on both the GLP toxicology services and SPF animal supply sides, but at vastly greater scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivo Bio Tech